Literature DB >> 30652266

Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models.

Bihua Bie1, Jiang Wu1, Joseph F Foss1, Mohamed Naguib2,3.   

Abstract

Microglia and complements appear to be involved in the synaptic and cognitive deficits in Alzheimer's disease (AD), though the mechanisms remain elusive. In this study, utilizing two types of rodent model of AD, we reported increased complement C1q-mediated microglial phagocytosis of hippocampal glutamatergic synapses, which led to synaptic and cognitive deficits. We also found increased activity of the metabotropic glutamate receptor 1 (mGluR1) in hippocampal CA1 in the modeled rodents. Artificial activation of mGluR1 signaling promoted dephosphorylation of fragile X mental retardation protein (FMRP) and facilitated the local translation machinery of synaptic C1q mRNA, thus mimicking the C1q-mediated microglial phagocytosis of hippocampal glutamatergic synapses and synaptic and cognitive deficiency in the modeled rodents. However, suppression of mGluR1 signaling inhibited the dephosphorylation of FMRP and repressed the local translation of synaptic C1q mRNA, which consequently alleviated microglial phagocytosis of synapses and restored the synaptic and cognitive function in the rodent models. These findings illustrate a novel molecular mechanism underlying C1q-mediated microglial phagocytosis of hippocampal glutamatergic synapses in AD.

Entities:  

Keywords:  Alzheimer’s disease; Complement C1q; Fragile X mental retardation protein; Metabotropic glutamate receptor; Microglial phagocytosis; Synaptic loss

Year:  2019        PMID: 30652266      PMCID: PMC6615956          DOI: 10.1007/s12035-019-1467-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  16 in total

Review 1.  Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.

Authors:  H-F Wei; S Anchipolovsky; R Vera; G Liang; D-M Chuang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-03       Impact factor: 3.784

2.  Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's disease.

Authors:  Supriya Ramesha; Sruti Rayaprolu; Christine A Bowen; Cynthia R Giver; Sara Bitarafan; Hai M Nguyen; Tianwen Gao; Michael J Chen; Ngozi Nwabueze; Eric B Dammer; Amanda K Engstrom; Hailian Xiao; Andrea Pennati; Nicholas T Seyfried; David J Katz; Jacques Galipeau; Heike Wulff; Edmund K Waller; Levi B Wood; Allan I Levey; Srikant Rangaraju
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 12.779

Review 3.  Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration.

Authors:  Christopher M Henstridge; Makis Tzioras; Rosa C Paolicelli
Journal:  Front Cell Neurosci       Date:  2019-02-26       Impact factor: 5.505

Review 4.  Intersection of pathological tau and microglia at the synapse.

Authors:  Thomas Vogels; Adriana-Natalia Murgoci; Tomáš Hromádka
Journal:  Acta Neuropathol Commun       Date:  2019-07-05       Impact factor: 7.801

Review 5.  Synaptic Elimination in Neurological Disorders.

Authors:  Pablo L Cardozo; Izabella B Q de Lima; Esther M A Maciel; Nathália C Silva; Tomas Dobransky; Fabíola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 6.  Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.

Authors:  Yunying Yang; Zhentao Zhang
Journal:  Front Aging Neurosci       Date:  2020-05-14       Impact factor: 5.750

7.  Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer's Disease-Like Neuropathology in Tg2576 Mice.

Authors:  Siok Lam Lim; Diana Nguyen Tran; Zanett Kieu; Christine Chen; Emmanuel Villanueva; Sagar Ghiaar; Victoria Gallup; Joannee Zumkehr; David H Cribbs; Carlos J Rodriguez-Ortiz; Masashi Kitazawa
Journal:  Mol Neurobiol       Date:  2020-03-07       Impact factor: 5.590

8.  Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.

Authors:  Jiang Wu; Bihua Bie; Joseph F Foss; Mohamed Naguib
Journal:  Mol Neurobiol       Date:  2020-02-01       Impact factor: 5.590

Review 9.  Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.

Authors:  Mujtaba Aamir Bhat; Khurshid Ahmad; Mohd Sajjad Ahmad Khan; Mudasir Ahmad Bhat; Ahmad Almatroudi; Safikur Rahman; Arif Tasleem Jan
Journal:  Biomolecules       Date:  2020-06-05

10.  Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex.

Authors:  Dibyadeep Datta; Shannon N Leslie; Yury M Morozov; Alvaro Duque; Pasko Rakic; Christopher H van Dyck; Angus C Nairn; Amy F T Arnsten
Journal:  J Neuroinflammation       Date:  2020-01-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.